Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO[R] (Sulbactam-Durlobactam)

Source :: Business Wire. November 21, 2024
Publication Year :: 2024
Abstract: SHANGHAI & CAMBRIDGE, Mass. -- Zai Lab ('Zai Lab', NASDAQ: ZLAB; HKEX: 9688) and Pfizer ('Pfizer', NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug XACDURO([R])(sulbactam-durlobactam) in [...]

Subjects :: Pfizer Pharmaceuticals Ltd. -- International economic relations
Zai Lab Ltd. -- International economic relations
Sulbactam -- Health aspects
Antibacterial agents -- Health aspects
Pharmaceutical industry -- International economic relations
Business
Business, international
Xacduro (Medication) -- Health aspects

Tools